News
KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-yearPhase 3 TEBE-AM trial on track to complete enrollment in 1H 2026Dose selection for PRISM-MEL-301 ...
KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 Dose selection for PRISM-MEL-301 ...
Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...
Brandon Blackstock’s heartbreaking death at 48 has left fans and family in mourning. Best known as Kelly Clarkson’s ...
Talent manager and Kelly Clarkson‘s ex-husband, Brandon Blackstock, has died after a three-year private battle with melanoma.
IDEAYA Biosciences' clinical trial progress, strong financials, and diversified pipeline signal long-term growth potential ...
Explore life-changing cancer care. Dr. Udai Kammula, who leads the solid tumor cell therapy program at UPMC Hillman Cancer ...
Danielle Lloyd has undergone surgery after being diagnosed with skin cancer. The former Celebrity Big Brother star opened up ...
"When they were out of style they were seen as an imperfection, now they're associated with the summer and an active ...
These 10 stocks could mint the next wave of millionaires › IDEAYA Biosciences (NASDAQ:IDYA), a precision oncology company focused on developing targeted therapies for cancer, reported its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results